Creating a Sustainable Impact: Fosun International Releases 2025 ESG Report and Climate Information Disclosures Report
Rhea-AI Summary
Fosun International (OTC:FOSUF) released its 2025 ESG Report and fourth Climate Information Disclosures Report on April 28, 2026. Key disclosures include a mid-term target to reduce Scope 1 and 2 GHG intensity by 20% by 2034 (2024 base), a commitment to peak emissions by 2028 and achieve carbon neutrality by 2050, and completion of a USD910 million three-year sustainability-linked syndicated loan. The Group reports upgraded ESG scores (MSCI AAA) and highlights green certifications, sustainable tourism progress, health‑care pipeline milestones, and total assets of RMB716.2 billion as of December 31, 2025.
Positive
- MSCI ESG rating upgraded to AAA
- Completed USD910 million three-year sustainability-linked syndicated loan
- Scope 1 and 2 GHG intensity target: -20% by 2034 (2024 base)
- Total assets reported at RMB716.2 billion as of 31 Dec 2025
- HANSIZHUANG approved in 40+ countries; global commercial progress
- Fosun Pharma reports >88 million severe malaria patients saved (doses supplied)
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
As an industry group rooted in
Actively driving global sustainable development and achieving outstanding ESG ratings
Driven by "innovation" and "globalization", Fosun actively advances the integration of ESG into its businesses, accelerates low-carbon transition, increases responsible investment, and strengthens social initiatives. By "Combining Global Resources with
Over the past year, despite global economic, environmental, and social uncertainties, Fosun remained steadfast in its long-term sustainability commitment and delivered strong results. According to the latest MSCI rating model (version 5.0), Fosun International's MSCI ESG rating has been upgraded to AAA. It has maintained a Hang Seng Sustainability Rating of AA-. It has also been included in S&P Global's Sustainability Yearbook 2026 and consistently ranked among the top
Actively responding to climate change and promoting low-carbon transition
In response to climate change and low-carbon transition, Fosun actively responds to the national "dual carbon" goals by promoting carbon neutrality and energy conservation and emissions reduction. In 2021, Fosun made a commitment to society – "strive to peak carbon emissions by 2028 and achieve carbon neutrality by 2050". Fosun has formulated strategies for climate change mitigation and adaptation to align with the 1.5°C temperature control target set in the Paris Agreement. Building on its commitment to achieve carbon neutrality by 2050, Fosun has set a mid-term target to reduce the intensity of Scope 1 and Scope 2 GHG emissions by
Regarding green finance, Fosun continues to leverage sustainability-linked financing instruments to expand funding sources for low-carbon and sustainable transition. In 2025, Fosun completed the refinancing of its maturing syndicated loan, arranging a new three‑year sustainability‑linked syndicated loan with an initial tranche equivalent to
The Group actively encourages its member companies to carry out climate actions. The Bund Finance Center (BFC), Fosun's main office and a landmark in
Fosun Insurance Portugal (Fidelidade) announced the launch of the Impact Center for Climate Change (ICCC) at
Concurrently, Fidelidade released its innovative investment program — Florestas de
In 2025, Fosun continued to leverage low-carbon technologies to organize the Yuyuan Lantern Festival, putting carbon neutrality into practice and incorporating oriental lifestyle aesthetics into sustainable development. Supported by Fosun's global platform, the Yuyuan Lantern Festival has gone international, having been held successively in
Leveraging innovation to bring hope of cure to patients
Fosun adheres to an innovation-driven strategy, upholding its original aspiration of bringing hope of cure to more patients. Targeting unmet medical needs, its Health business segment's strategic focus is on key therapeutic areas including oncology, immunology and inflammation, and neurodegenerative diseases, while actively expanding into cardiometabolic diseases and rare diseases. This approach enables the development of high valued competitive pipelines and comprehensive healthcare solutions. Meanwhile, it continues to consolidate its core technical platforms including but not limited to antibodies and antibody-drug conjugates (ADCs), small molecules and cell therapies. Additionally, it actively advances cutting-edge therapeutic modalities such as radiopharmaceuticals and small nucleic acids.
Among them, HANSIZHUANG, HLX43, HLX22, and other marketed and pipeline innovative drugs have delivered several "world's first" breakthroughs. HANSIZHUANG became the world's first monoclonal antibody targeting PD-1 approved for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), and has been approved for marketing in over 40 countries and regions. HLX43 has shown significant advantages, with a favorable efficacy and safety profile in non-small cell lung cancer (NSCLC), gynecological tumors, esophageal squamous cell carcinoma (ESCC), and other indications. HLX22 is the world's first anti-HER2-targeted therapy to receive Orphan Drug Designation (ODD) approvals from both US Food and Drug Administration (FDA) and the European Commission (EC) for gastric cancer.
In addition, Fosun Pharma continues to support the health development of African communities. As of 31 December 2025, Fosun Pharma's independently developed artesunate for injection had saved more than 88 million severe malaria patients worldwide, with more than 440 million doses supplied globally.
Business for good, actively giving back to society
Fosun remains committed to "Business for Good". In order to better promote the fulfilment and implementation of corporate social responsibility, Fosun Foundation was established in 2012. It has been making unremitting efforts in the fields of global emergency relief, rural revitalization, health, education, culture and art, youth development, etc. to create social value. Fosun Foundation has continued to advance the Rural Doctors Program. Since its launch in 2017, the program has covered 78 counties in 16 provinces, cities, and autonomous regions across the country, supporting 25,000 rural doctors and benefiting 3 million rural families. In addition, it has introduced the "AI Rural Doctor Assistant" to grassroots communities to enhance the coverage and efficiency of medical services.
Linking ESG performance to Board appraisal through a top-down, long-term ESG mechanism
Fosun has established a top-down and long-term mechanism for ESG improvement and has included ESG management performance as an evaluation factor in the Executive Directors' performance assessment, and the ESG management performance appraisal mechanism is also extended to the CEOs of the Group and the personnel in charge of each business group. Fosun has set up an ESG Board Committee under the Board of Directors (the "Board") to assist the Board in guiding and overseeing the Group's ESG development and implementation. At the management and decision level, Fosun has established an ESG Executive Committee under the management to provide decision support for the implementation of ESG strategies. At the implementation level, the Group has also set up an ESG Management Committee and an ESG Working Group to implement ESG strategies and related actions and ensure the establishment of appropriate and effective ESG risk management and internal control system.
Looking ahead, Fosun will continue to focus on its core businesses, uphold innovation, and pursue globalization. At the same time, Fosun will continue to closely follow global sustainability trends, continuously refine its ESG management, actively respond to national strategies, ensure information security, implement "dual carbon" goals, participate in philanthropic initiatives, and protect employees' rights and interests. Leveraging the resources and advantages of its global industrial ecosystem, Fosun endeavors to make a greater impact on sustainable development and continuously contribute to a better world.
For more information on Fosun's ESG, please refer to Fosun International's ESG Report 2025 posted on the Hong Kong Stock Exchange's website (http://www.hkexnews.hk)
or the Company's ESG webpage (https://en.fosun.com/esg/)
The electronic copy of the Climate Information Disclosures Report 2025 is available on the Company's ESG webpage (https://en.fosun.com/esg/)
About Fosun
Fosun was founded in 1992. After more than 30 years of development, Fosun has become a global innovation-driven consumer group. Adhering to the mission of creating happier lives for families worldwide, Fosun is committed to creating a global happiness ecosystem fulfilling the needs of families in Health, Happiness and Wealth. In 2007, Fosun International Limited was listed on the main board of the Hong Kong Stock Exchange (stock code: 00656.HK). As of 31 December 2025, Fosun International's total assets amounted to
View original content:https://www.prnewswire.com/news-releases/creating-a-sustainable-impact-fosun-international-releases-2025-esg-report-and-climate-information-disclosures-report-302755862.html
SOURCE Fosun